NRX Pharmaceuticals, Inc. Investment Income, Interest
NRX Pharmaceuticals, Inc. (NRXP) reported Investment Income, Interest of $6.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- NRX Pharmaceuticals, Inc. investment income, interest for the quarter ending 2026-06-30 was $6.00K, a 200.00% increase year-over-year.
- NRX Pharmaceuticals, Inc. investment income, interest for the quarter ending 2026-03-31 was $5.00K, a 25.00% increase year-over-year.
- NRX Pharmaceuticals, Inc. investment income, interest for the quarter ending 2025-12-31 was $4.00K, a 0.00% change year-over-year.
- NRX Pharmaceuticals, Inc. investment income, interest for the quarter ending 2025-09-30 was $2.00K, a 66.67% decline year-over-year.
- NRX Pharmaceuticals, Inc. investment income, interest for fiscal 2025 was $12.00K, a 72.73% decline from fiscal 2024.
- NRX Pharmaceuticals, Inc. investment income, interest for fiscal 2024 was $44.00K, a 91.09% decline from fiscal 2023.
- NRX Pharmaceuticals, Inc. investment income, interest for fiscal 2023 was $494.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.00K 10-Q · filed 2026-08-14 | $11.00K 10-Q · filed 2026-08-14 | $15.00K derived: sum of 3 quarters · filed 2026-08-14 | $17.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $5.00K 10-Q · filed 2026-05-15 | $9.00K derived: sum of 2 quarters · filed 2026-05-15 | $11.00K derived: sum of 3 quarters · filed 2026-05-15 | $13.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $6.00K derived: sum of 2 quarters · filed 2026-03-23 | $8.00K derived: sum of 3 quarters · filed 2026-08-14 | $12.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-14 | $4.00K derived: sum of 2 quarters · filed 2026-08-14 | $8.00K 10-Q · filed 2025-11-14 | $12.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-14 | $6.00K 10-Q · filed 2026-08-14 | $10.00K derived: sum of 3 quarters · filed 2026-08-14 | $16.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-15 | $8.00K derived: sum of 2 quarters · filed 2026-05-15 | $14.00K derived: sum of 3 quarters · filed 2026-05-15 | $21.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $10.00K derived: sum of 2 quarters · filed 2026-03-23 | $17.00K derived: sum of 3 quarters · filed 2026-03-23 | $44.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $6.00K 10-Q · filed 2025-11-14 | $13.00K derived: sum of 2 quarters · filed 2025-11-14 | $40.00K 10-Q · filed 2025-11-14 | $114.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $7.00K 10-Q · filed 2025-08-18 | $34.00K 10-Q · filed 2025-08-18 | $108.00K derived: sum of 3 quarters · filed 2025-08-18 | $227.00K derived: sum of 4 quarters · filed 2025-08-18 |
| 2024-03-31 | $27.00K 10-Q · filed 2025-05-15 | $101.00K derived: sum of 2 quarters · filed 2025-05-15 | $220.00K derived: sum of 3 quarters · filed 2025-05-15 | $365.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $193.00K derived: sum of 2 quarters · filed 2025-03-14 | $338.00K derived: sum of 3 quarters · filed 2025-03-14 | $494.00K 10-K · filed 2025-03-14 |
| 2023-09-30 | $119.00K 10-Q · filed 2024-11-14 | $264.00K derived: sum of 2 quarters · filed 2024-11-14 | $420.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $145.00K 10-Q · filed 2024-08-14 | $301.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $4.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |